RxDoctor Payments Data

Sean Snowden, PA

Physician Assistant · Hendersonville, NCNPI 1194360511

Payments from drug & device makers

$1,698in general payments, 2019–2025

Across 90 payments — averaging $18.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$480
  • Gilead$200
  • Johnson & Johnson$176
  • Takeda Pharmaceuticals U.S.A., Inc.$163
  • Phathom Pharmaceuticals, Inc.$143
  • Ironwood Pharmaceuticals, Inc$89
  • plus $447 from 11 others

What the payments were for

  • Food & beverage$1,64397%
  • Education$553%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,698 in reported general payments places this provider in the 75th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$62,069
Medicare patients
375
Services billed
562

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ZenpepLipase/Protease/Amylase37$131,455
LinzessLinaclotide23$21,777
Sucralfate43$5,105
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl232$3,918
Omeprazole166$3,305
Colestipol Hcl30$3,086
ClenpiqSod Picosulf/Mag Ox/Citric Ac16$2,742
PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C18$2,570
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates22$1,389
Pantoprazole Sodium51$1,133
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl47$663
Rabeprazole Sodium17$518
Esomeprazole Magnesium12$461
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg19$448
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl14$247

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$480$21,77723 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCPlenvu$79$2,57018 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Hendersonville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →